ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000248964.2	Tanespimycin	Breast invasive carcinoma	0.00596935	Resistant
ENSG00000248964.2	Tanespimycin	Chronic Lymphocytic Leukemia	0.048860971	Resistant